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Abstract
Background: Sperm-egg interaction defect is a significant cause of in-vitro fertilization failure for infertile cases.
Numerous molecular interactions in the form of protein-protein interactions mediate the sperm-egg membrane
interaction process. Recent studies have demonstrated that in addition to experimental techniques, computational
methods, namely protein interaction network approach, can address protein-protein interactions between human
sperm and egg. Up to now, no drugs have been detected to treat sperm-egg interaction disorder, and the initial
step in drug discovery research is finding out essential proteins or drug targets for a biological process. The main
purpose of this study is to identify putative drug targets for human sperm-egg interaction deficiency and consider
if the detected essential proteins are targets for any known drugs using protein-protein interaction network and
ingenuity pathway analysis.
Results: We have created human sperm-egg protein interaction networks with high confidence, including 106 nodes
and 415 interactions. Through topological analysis of the network with calculation of some metrics, such as
connectivity and betweenness centrality, we have identified 13 essential proteins as putative drug targets. The
potential drug targets are from integrins, fibronectins, epidermal growth factor receptors, collagens and tetraspanins
protein families. We evaluated these targets by ingenuity pathway analysis, and the known drugs for the targets have
been detected, and the possible effective role of the drugs on sperm-egg interaction defect has been considered.
These results showed that the drugs ocriplasmin (Jetrea©), gefitinib (Iressa©), erlotinib hydrochloride (Tarceva©), clingitide,
cetuximab (Erbitux©) and panitumumab (Vectibix©) are possible candidates for efficacy testing for the treatment of
sperm-egg interaction deficiency. Further experimental validation can be carried out to confirm these results.
Conclusion: We have identified the first potential list of drug targets for human sperm-egg interaction defect using the
protein interaction network approach. The essential proteins or potential drug targets were found using topological
analysis of the protein network. These putative targets are promising for further experimental validation. These study
results, if validated, may develop drug discovery techniques for sperm-egg interaction defect and also improve assisted
reproductive technologies to avoid in-vitro fertilization failure.
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Background
Sperm-egg interaction is one of the most significant pro-
cesses in the fertilization event, and the disorder in this
process is the main cause of fertilization failure in com-
mon in-vitro fertilization (IVF) cases with unexplained
male infertility [1, 2]. The molecular interaction process
surrounding sperm-oocyte binding and fusion have been
studied in various attempts over the past 20 years and is
still poorly understood. Due to detection of the mole-
cules that immediate human membrane sperm-oocyte
interaction, different experimental methods have been
carried out [3]. In our previous research (refer to [4, 5]),
we have represented that in addition to experimental
techniques, computational methods, protein interaction
network approach, can address protein-protein interac-
tions between human sperm and egg; we have shown
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the links between the sperm and egg proteins in the
form of a protein interaction network. Several research
questions associated with the function of single or
groups of interacting proteins can be answered with the
help of protein-protein interaction (PPI) networks [6].
Essential proteins for a biological event play a complex
role in the development of the process, and the discov-
ery of their features is an interesting research subject in
proteomics. A protein’s essentiality has been used in nu-
merous medical and biological researchers in recent
years. Currently essential proteins are recognized based
on gene knockout experiments, which can be expensive
and time consuming when the biological experiments
are carried out on a large-scale basis. Therefore, re-
searchers still lack understanding regarding a large num-
ber of proteins’ lethality information; thus, alternative
detection approaches are being pursued. Computational
methods can supply the knowledge of biological infor-
mation. The absence or dysfunction of essential proteins
would create an adverse disruption to the topological
stability of the network as in the case of PIN biological
lethality. This laid the foundation in which computation
methods based on topological features are developed to
better detect essential proteins [7–11]. Recent experi-
mental protein interaction networks of Saccharomyces
cerevissiae and Caenorhabditis elegans [8, 12] have been
carried out to confirm the effectiveness of topological
metrics in predicting protein essentiality, demonstrating
strong correlation with knockout and knockdown data.
Until now, no drugs have been identified to treat infer-
tile cases who have a disorder of the sperm-egg inter-
action process. The drug discovery process begins with a
search for drug targets or essential proteins. Because of
the networked nature of protein function, topological
analysis of the protein network may help to identify es-
sential proteins that can be potentially drug targets.
In this work, we analyzed the human sperm-egg pro-
tein interaction network with topological metric of con-
nectivity, betweenness centrality in order to identify
essential proteins as putative drug targets using Cytos-
cape 2.8. Ingenuity pathway analysis (IPA) was used to
identify the drugs for these targets to determine the pos-
sible effectiveness of these drugs on sperm-egg inter-
action disorder. The list of putative protein targets is a
starting point for experimental validation by in vitro as-
says and further discovery of new drugs in order to treat
the sperm-egg interaction defect.
Methods
Construction of sperm-egg protein-protein interaction
network
Information found in PPIs databases supports the con-
struction of interaction networks. All retrieved data from
the various data sources (refer to [4, 5]) were combined
and loaded into Cytoscape 2.8 [13] to construct the pro-
tein interaction network (PIN). Two PINs for sperm
proteins and oocyte proteins have been created, and
then intersection (overlapping) network has been con-
structed using a network modification plugin (compare
two networks) in Cytoscape. Because our primary aim
was to identify protein candidates involved in sperm-egg
interactions, we extracted only the proteins that contain
a signal sequence and/or transmembrane domain [14]
by selecting signal peptide and transmembrane features
from sequence annotation (features) in an extensively
curated UniProt database (www.uniprot.org) (for more
details refer to [4, 5]).
Selecting high confident protein interactions
In this study, only the high confidence protein-protein in-
teractions (STRING scores ≥ 0.700 and MINT-inspired
(MI) scores ≥ 0.431) were filtered. STRING (string-db.org)
uses a score combiner based on the product of probabil-
ities using the following formula: S ¼ 1−
YN
i
1−Sið Þ , with
Si the probability score for database i, S the combined
score and N the total number of databases to be com-
bined. The combined scores were further rescaled into the
confidence range from 0.0 to 0.1 combining all the scores.
Those indicate: <0.400 (low confidence), 0.400–0.700
(medium confidence) and >0.700 (high confidence). As a
result, the high confidence PPI’s (>0.700) were selected
[15]. The MINT-inspired (MI) score was assigned based
on an earlier approach [16] and it was adopted their confi-
dence score formula (http://wodaklab.org/iRefWeb/). To
create a high-confidence set of interactions, the following
procedure was applied; first include the physical interac-
tions; then exclude interactions that are supported by less
than three publications or that are not conserved in any
species and finally retain pairs with an MI-score of at least
0.431 [17]. To avoid a false positive result of experimental
detection for physical interactions and to create a high
confidence set of physical interactions, the pairs of inter-
actions with an MI- score of at least 0.431 remain [17].
Identification of putative drug targets with topological
analysis
Topological parameters have been defined to measure
network characteristics using Cytoscape Network
Analyzer plug-in v. 2.8. This plugin is a tool that helps
to study the topology and the parameters of a network
by using descriptive statistics and graphs. Power law fit
for the protein network was detected by calculating de-
gree exponent distribution and the coefficient of deter-
mination. The shortest path (geodesics) was calculated
to evaluate the network and parameters, such as de-
gree (connectivity), betweenness centrality (BC) and
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closeness centrality (CC), were used to detect the es-
sential proteins as putative drug targets.
Detection of the drugs for the putative drug targets
The name of the essential proteins or the identified puta-
tive drug targets were submitted in IPA software (http://
www.ingenuity.com/), and using disease view feature of
IPA, the known drugs for these targets have been de-
tected. We have also demonstrated the hypothetical effect-
iveness of the drugs on sperm-egg interaction disorder.
Result and discussion
Construction of sperm-egg interaction network
In order to construct a sperm-egg interaction network,
the sperm protein network including 2076 protein nodes
and 8565 interactions and an oocyte protein interaction
network including 409 protein nodes and 2746
interactions has been created. Then, the intersection
(overlapping) network was calculated using a network
modification plugin (compare two networks) in Cytos-
cape 2.8. The overlapping protein interaction network,
namely the sperm-egg interaction network, consists of
167 nodes and 3634 interactions. From these proteins,
106 proteins that contain a signal sequence and/or
transmembrane domain were extracted. A variety of da-
tabases that are based on the used features and the num-
ber of released PPI in sperm-egg interaction from these
databases are detailed in the Additional file 1: Table S1
and S2. The extracted protein network as shown in Fig. 1
consists of 106 nodes and 1484 interactions.
Selecting high confidence predicted protein interactions
In this study, to avoid false positive results of predicted
PPIs, the “combined score” between any pair of proteins
Fig. 1 Sperm-Egg Protein Interaction Network. The intersection (overlapping) network between sperm and oocyte PIN was calculated using a
network modification plugin (compare two networks) in Cytoscape 2.8. From these proteins, 106 proteins that contain a signal sequence and/or
transmembrane domain were extracted. The created protein network consists of 106 nodes and 1484 interactions
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was calculated using STRING database (string-db.org).
As a result, only the interactions in the human sperm-
egg interaction network with high confidence (>0.700)
PPIs were filtered. To elude false positive results of ex-
perimental detection for physical interactions and to cre-
ate a high confident set of physical interactions, the
pairs of interactions that are supported by at least three
publications and that have an MI-score of at least 0.431
remain (http://wodaklab.org/iRefWeb/).
After extracting the high confident PPIs, there were
two networks: the network with high confident PPI
based on STRING scores that includes 96 proteins and
362 interactions and the physical interaction network
with 90 proteins and 186 interactions, as summarized in
Table 1. Two created networks were merged to achieve a
union network. The retrieved network includes 106
nodes and 415 edges (See Fig. 2).
Topological analysis of protein interaction network
The biological networks have been represented to have a
power law degree distribution, which follows scale-free
topology. This important feature of biological networks
is significant for a credible prediction of essentiality
when the factors of connectivity and betweenness cen-
trality are utilized. Furthermore, it is described that most
of the biological networks in nature have a degree expo-
nent amount between two and three [18, 19]. The expo-
nent degree and R2 coefficient (for degree distribution)
of the sperm-egg interaction network were measured
using the least square method by a network analysis plu-
gin of Cytoscape. The PPIs in the created network have
been filtered for only high confidence (STRING score >
0.7 for functional and predicted interactions and MI
score ≥ 0.431 for physical interactions). The created net-
work with high confident PPIs in an exponent of −1.1
(R2 = 0.9) was compatibly better with a scale-free top-
ology and also provides to assert with more reliability
that a discovered hub and bottleneck node may be es-
sential for the network [18–20]. The shortest paths ana-
lysis of the network demonstrated that any two
randomly selected nodes on the network were connected
by 3.4 links. The results show that the nodes of the net-
work were very closely linked and were similar to other
deals of human protein networks [19]. The distribution
of the shortest paths was represented using a histogram,
as shown in Fig. 3.
Detection of the putative drug targets
In a scale free distribution, the presence of low number
of highly connected nodes known as hubs is more sig-
nificant than lesser connected nodes. The hub nodes, as
represented in Fig. 4, play an important role in the sur-
vival of correlations within a biological network. If the
hub nodes are attacked in a network, the network can
be broken into pieces. The node with a large BC value is
another important node that functions as a bottleneck in
the network, even when the degree of node is low. Half
of the maximum degree and BC of the network were
used as the critical point of high degree and high BC
nodes [18, 19, 21, 22]. In order to check topological cen-
trality of hubs and bottlenecks in the network, CC
values of the protein set were measured. The degree,
BC, CC and the protein family of the important nodes
are shown in Table 2.
The predominant aspect of hub and bottleneck protein
nodes in a biological protein interaction network is that
they are potential drug targets. If functions of hubs and
bottlenecks are inhibited by small molecules, the process
of the network can be stopped; on the other hand, the
studying processes can be shut down, theoretically.
Experimental evidence for the essentiality of predicted
potential drug targets
The result revealed five protein families with high degree
nodes within the network, as stated in Fig. 4 and Table 2.
Integrins are a family of cell adhesion molecules that fa-
cilitate cell-extracellular and cell-cell matrix interactions
[23, 24] that similarly have been contributed as posses-
sing a part in association with mammalian sperm-egg in-
teractions. Integrins are heterodimeric transmembrane
proteins constituted of an “α” and a “β” subunit, includ-
ing 18 α and 8 β subunits in mammals. (Mouse Genome
Database and Human Genome Organization nomencla-
tures mention them as ITGB and ITGA subunits, re-
spectively). Based on ligand specificity and on sequence
homologies of the subunits, the 24 acknowledged het-
erodimer combinations are categorized into five different
subfamilies [23, 25, 26]. Moreover, the ADAM (a disinte-
grin and metalloproteinase) is one of the most recently
described groups of integrin ligands. An anti ITGB1
function-blocking antibody which decreases sperm-egg
binding considerably inhibited ADAM2 adhesion to
mouse oocytes. Referring to Fig. 5, the mouse oocytes
can be expressed in diverse integrins as indicated by ana-
lysis of integrin subunit expression, i.e. ITGA9-ITGB1,
laminin-binding family collagen-binding family and Arg-
Gly-Asp (RGD)-binding family (such as, vitronectin,
Table 1 The high confident PPI in sperm-egg interaction
network
Type of interactions Proteins PPI
High confident PPI (>0.700) based on
STRING scores
96 362
High confident physical interactions
(≥0.431) based on MI scores
90 186
After extracting the high confident PPIs, there were two networks: the
network with high confident PPI based on STRING scores that includes 96
proteins and 362 interactions and the physical interaction network with 90
proteins and 186 interactions
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fibronectin). Adhesion analysis has characterized that
ADAM2 interactions with ITGA9/ITGA4 family [27].
Figure 5 shows that ITGB1 can interact with other
subunits, and previous studies have already demon-
strated that integrin β1 was overexpressed in infertile
men. Itgb1-deficient eggs in mice have demonstrated an
interruption in sperm-egg adhesion in time-lapse video
analysis, and slight deficiencies have been detected with
Itga3-deficient eggs in modified analyses. A decrease in
sperm-egg fusion and binding was shown in the oocytes
with 50 % knockdown of ITGA9 on the oocyte surface
as well as the reduction of the fertilized eggs percentage
in comparison to the controls, but ITGA9 knockdown
did not bring a comprehensive loss of fertilization ability.
Fig. 2 The Sperm-Egg Interaction Network with High Confident PPI Based on STRING Scores and MI Scores. Two created networks with high
confident PPIs were merged to achieve a union network. The retrieved network includes 106 nodes and 415 edges
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This occurred possibly due to a partial decrease of
ITGA9 on the oocyte surface and because of likely func-
tion of other molecules on the oocyte surface in gamete
membrane adhesion [28, 29]. However, oocyte integrins,
mainly the ITGA9 α subunit, possess the prospect to
contribute to sperm-oocyte interactions with wild-type
oocytes, although data from knockouts establish that oo-
cytes lacking in several integrins are still able to be fertil-
ized. The presented result showed that ITGA9 interacts
with ITGB1 as a hub protein in the created human
sperm-egg interaction. Due to previous studies, the incu-
bation of bull spermatozoa with integrin beta 5
antibodies considerably reduced the capability of fertiliz-
ing the oocyte. The results have recommended that dur-
ing fertilization, the bovine sperm integrin beta 5
protein plays an important role and could serve as a
functional or a positional marker of bull fertility [30].
The CD9 in the network is a hub node to facilitate the
sperm-egg interaction. CD9 and other tetraspanins are
possibly taking part in the adjustment of membrane di-
rected by connecting to and/or enabling the acting of
other membrane proteins. CD9-associated proteins in
other cell categories are comprised of IgSF members,
numerous integrins and other adhesion molecules,
ectoenzymes and several intracellular signalling mole-
cules. However, there is only restricted information re-
garding CD9-associated proteins in oocytes. IgSF8 co
immune precipitates withCD9 in oocyte lysates and is
lacking from the Cd9-null eggs’ surfaces [3, 31].
Fibronectin (FN) binds to the cell surface via integrins,
which are transmembrane protein receptors. The integ-
rins identify the Arg-Gly-Asp (RGD) amino acid se-
quence in FN. Following capacitation, the human sperm
express FN on their surface, and FN is also secreted dur-
ing cumulus penetration. Association of FN and its α5β1
integrin receptor with IVF has previously been revealed
in a number of species [32, 33].
Furthermore, FN is a constituent of the seminal fluid
and a ubiquitous multifunctional glycoprotein that plays
an important role in the formation of seminal gel after
ejaculation. It can bind to cellular components that are
visible once spermatozoa is impaired and consequently
Fig. 3 Histogram of Distribution of the Shortest Path. The shortest
paths analysis of the network demonstrated that any two randomly
selected nodes on the network were connected by 3.4 links. The
results show that the nodes of the network were very closely linked
and were similar to other deals of human protein networks
Fig. 4 Color Filtered Sperm-Egg Interaction Network by Degree from 1–33. The degree tells us how many links a node has to other nodes. The
high degree nodes as hub nodes play important roles in the survival of correlations within a biological network. If the hub nodes are attacked in
a network, the network can be broken into pieces
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assists in selecting damaged spermatozoa [34, 35]. An
increase in fibronectin expression of infertile patients
compared to fertile cases has been reported [36].
Epidermal growth factor receptors (EGFRs) are recep-
tor tyrosine kinases and are activated by a big family of
peptidic ligands that persuade the constitution of active
auto (trans)-phosphorylated receptor homo-/heterodi-
mers. Upon recruitment of signalling proteins and adap-
tors, the active dimers start multiple signalling procedures
[37]. It has been shown previously that bovine sperm
comprises EGFR, localized to the sperm head and the
mid-piece. Also, it has been revealed that during sperm
capacitation, EGFR is involved in the AR [38–40]. In
addition, EGFR phosphorylation/activation is increased
during capacitation. While further stimulation of the
EGFR in capacitated sperm reveals augmented intracellu-
lar calcium amounts, leading to AR [38]. A scan of the
microarray device showed that zona pellucida glycopro-
tein 3 (ZP3) interacted with EGFR, and EGFR is a new
suggested sperm receptor for ZP3. EGFR-null sperm show
very low binding to the egg as well as reduced IVF rate,
emphasizing the role of EGFR and its necessity for effi-
cient sperm-egg interaction for normal fertilization [41].
Collagens are members of the extracellular matrix pro-
teins family that plays a significant role in developing
processes and are essential structural components of or-
gans and tissues, comprising skin, lung, blood vessels
and bone. A key collagenous constituent, Type I colla-
gen, functions in neural crest cell migration and may be
linked to the regulation of cellular variation. Col1a1 have
been recognized from published microarray experiments
on normal human tissue [33, 42, 43], and there is a high
level of expression in reproductive tissues. Col1a1 is
greatly stated in the uterus and plays a significant role
during spermatogenesis where it facilitates the migration
and detachment of germ cells. The function of procolla-
gen I in germ cells is associated with their ability to at-
tach and detach from the basement membrane, and it
seems that during spermatogenesis, procollagen I might
be included in regulating the connection of these germ
cells to the basement membrane inside the seminiferous
tubules. The damage of procollagen I expression may
announce a beginning of successive differentiation into
later germ cell kinds [33].
Integrins are membrane receptors that link cells to the
extracellular matrix, comprising collagen, and function
in regulating proliferation, cellular migration, survival
and differentiation. β1 integrin can make couple with
various α-subunits to make two main receptors for type
I collagen; in particular, α1β1 and α2β1 integrins are effi-
cient cellular receptor for type I collagen [44].
Detection of drugs for the putative drug targets
The known drugs for the identified drug targets could
be found using IPA as represented in Table 3. In Table 3,
the targets were arranged based on their degree in the
sperm-egg interaction network from high to low. IPA’s
data analysis and search capabilities show the signifi-
cance of the yield data, specific target, or candidate bio-
markers in the context of larger biological or chemical
systems.
As discussed in the topological analysis of PINs, the
high degree and high BC nodes in PPI networks from
the complex diseases are the putative drug targets for fu-
ture studies in diagnoses or medical treatments. Topo-
logical analysis of the sperm-egg protein interaction
Fig. 5 Different Types of Integrins [27]. The mouse oocytes can be
expressed in diverse integrins as indicated by analysis of integrin
subunit expression, i.e. ITGA9-ITGB1, laminin-binding family collagen-
binding family and Arg-Gly-Asp (RGD)-binding family (such as,
vitronectin, fibronectin)
Table 2 The high degree nodes with evaluated BC and CC in
sperm-egg protein network
Gene name Protein family Degree BC CC
ITGB1 Integrins 33 0.2 0.5




ITGA3 Integrins 25 0.03 0.5
ITGAV 24 0.03 0.5
ITGB3 23 0.02 0.5
COL1A1 Collagens 22 0.02 0.5
CD9 Tetraspanins 21 0.1 0.5
ITGB4 Integrins 20 0.04 0.5
ITGA5 19 0.04 0.5
ITGB8 18 0.01 0.4
ITGB5 17 0.01 0.4
ITGA2 17 0.01 0.4
Half of the maximum degree and BC of the network were used as the critical
point of high degree and high BC nodes and in order to check topological
centrality of hubs and bottlenecks in the network, CC values of the protein set
were measured. The proteins from integrin, fibronectin, epidermal growth
factor receptor, collagens and tetraspanin protein families are hub nodes that
have a large BC
BC betweennes centrality, CC closeness centrality
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network have been showed that FN1, EGFR, ITGAV,
ITGB3, COL1A1, ITGB5 have high degree and BC, and
it is assumed these proteins are putative drug targets for
future medical studies in treatment of hidden male infer-
tility or unsuccessful ART.
Increased expression of fibronectin has been reported
in infertile patients when compared with fertile cases
[36]. Fn and the integrin receptors for Fn (α5β1) in
humans exist on the spermatozoa surface after capacita-
tion, signifying that accumulated exogenous Fn perhaps
compete with those Fn molecules stated on the surface
of sperm in binding receptors on the ZP. Plasma Fn as
exogenous Fn lacks the fragment which includes a sec-
ond RGD sequence and intrinsically cannot function as
a sperm-oocyte linking molecule. A second RGD se-
quence is essential in order to apply this kind of velcro
function, and this second RGD sequence has a role in
several biological substitutes of Fn that are positioned
on the zona pellucida [45].
By combining the previously represented outcomes, it
can be presumed that the over expression of plasma
FN1 may inhibit the interaction of the endogenous FN
ligands with corresponding receptors on both sperm
cells and the oocyte plasma membrane. Until now, only
“Ocriplasmin (Jetrea©)” has been used to degrade fibro-
nectin. Ocriplasmin is a recombinant protease with ac-
tivity against fibronectin that is used for treatment of
symptomatic vitreomacular adhesion. However, the rela-
tionship between Ocriplasmin and fertility has not been
considered, and further studies need to design drugs that
can induce plasma FN1 degradation in over expressed
conditions.
Additionally, a scan of the microarray device displayed
that ZP3 interacted with EGFR which is a new suggested
sperm receptor for ZP3. On the other hand, EGFR-null
sperm revealed very low binding to the oocyte as well as
decreased IVF rate, emphasizing the role of EGFR and
its essentiality for efficient sperm-egg interaction for
normal fertilization [41]. Amplification or overexpres-
sion of EGFR has been revealed to play a significant role
in the progression and development of certain aggressive
types of breast cancer [46]. Although no medical rela-
tionship between overexpress of EGFR and infertility has
been reported, Meggiorini and his co-workers have
already established that female patients with primary in-
fertility may symbolize a group at greatest risk for breast
cancer [47]. Combining these results, it is assumed that
overexpression of EGFR might be a potential cause of
infertility.
EGFR has been identified as an oncogene that led to
the progression of anticancer therapeutics directed
against EGFR (called “EGFR inhibitors”). Many drugs
against EGFR are monoclonal antibody inhibitors which
block the extracellular ligand binding domain. Therefore,
the tyrosine kinase cannot be activated due to no attach-
ment of signal molecules. Cetuximab (Erbitux©) and
panitumumab (Vectibix©) are examples of monoclonal
antibody inhibitors [48]. Other types of drugs against
EGFR are small molecules to inhibit the EGFR tyrosine
kinase which is on the cytoplasmic side of the receptor.
Accordingly, EGFR is unable to activate itself, and by
stopping the signaling cascade in cells that is based on
this pathway, growth, migration and proliferation of
tumor will be diminished. Gefitinib (Iressa©) and erloti-
nib hydrochloride (Tarceva©) (mixed EGFR and ERBB2
inhibitor) are examples of small molecule kinase inhibi-
tors [49]. These drugs with EGFR inhibitor functions are
suggested to study their effects on infertile cases that
present overexpression of EGFR.
The integrins are membrane receptors that function
in regulating proliferation, cellular migration, survival
and differentiation and also link cells to the extracellu-
lar matrix comprising collagen. In order to constitute
two main receptors for type I collagen, β1 integrin can
couple with diverse α-subunits, namely α1β1 and α2β1
integrin [44].
According to the result of this study, β1 integrin
(ITGB1) has the highest degree in the sperm-egg inter-
action network and previously has been detected in both
sperm and egg [50]. The combining results show that
the type I collagen (COL1A1) induces the binding be-
tween sperm and oocyte through interaction with β1
Table 3 Known drug targets and drugs for the candidate protein in sperm-egg protein interaction Network
Protein name Drugs Degree
FN1 Ocriplasmin 30
EGFR Cetuximab, AEE 788, panitumumab, BMS-599626, varlitinib, XL647, afatinib, sapitinib, cetuximab/irinotecan,
erlotinib/gemcitabine, lapatinib/letrozole, canertinib, gefitinib, neratinib, PD 153035, lapatinib, vandetanib, erlotinib
25
ITGAV Abciximab, CNTO 95, cilengitide 24
ITGB3 Abciximab, TP 9201, cilengitide, tirofiban 23
COL1A1 Collagenase clostridium histolyticum 22
ITGB5 Cilengitide 17
The identified drug targets were arranged based on their degree in the sperm-egg interaction network from high to low. The known drugs for the targets were
found using IPA
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integrin receptors in both cells. COL1A1 is the target
for the Collagenase clostridium histolyticum (Xiaflex©)
drug. Collagenase clostridium histolyticum is an en-
zyme generated by the bacterium Clostridium histolyti-
cum that pull apart collagen. It is used in the form of a
powder-and-solvent injection kit for the treatment for
Dupuytren’s contracture, an illness in which the fingers
twist towards the palm and cannot be completely flat-
tened [51, 52]. Recently this medicine has been ap-
proved by FDA for males [53]. Due to the effect of this
drug in treatment these diseases, any relationship be-
tween this drug and sperm-egg interaction cannot be
found.
Overexpression of some type of integrins, such as
ITGB3, ITGB5 and ITGAV, has been associated with the
tumor metastasis in breast cancer. Targeting these cell
surface proteins could provide a possible assay to con-
sider the metastatic potential of tumors [54]. Addition-
ally, it has been reported that with primary infertility,
female patients might symbolize a group at great danger
of breast cancer [47]. The results of this study also show
the molecular aspects of the link between sperm-egg dis-
order and breast cancer. Combining these result, the up
regulation of ITGB3, ITGB5 and ITGAV could be as-
sumed may disturb sperm-egg binding and fusion and
fail successful fertility. Clingitide seems to inhibit tumor
regression by inhibiting these integrins [55, 56]. There-
fore, if the relationship between the up-regulated integ-
rins and sperm-egg binding perturbation are supported
by further experimental work, Clingitide could be an in-
teresting drug for future treatment of sperm-egg binding
disorder.
The roles of the mentioned drug targets on sperm-egg
interaction and the hypothetical effects of the drugs on
treatment of sperm-egg interaction defects are summa-
rized in Table 4.
Conclusion
This study constitutes the first attempt to determine a po-
tential list of drug targets for human sperm-egg inter-
action defects using a protein interaction network
approach. The detected targets are from integrins, fibro-
nectins, epidermal growth factor receptors, collagens and
tetraspanins protein families. The known drugs for the
identified targets have been identified using IPA, and the
possible roles of the drugs on sperm-egg interaction have
been discussed. These results showed that the drugs ocri-
plasmin (Jetrea©), gefitinib (Iressa©), erlotinib hydrochlor-
ide (Tarceva©), clingitide, cetuximab (Erbitux©) and
panitumumab (Vectibix©) are possible candidates for effi-
cacy testing on human sperm-egg interaction disorder for
further experimental validation. This strategy, if validated,
may develop established drug discovery methodologies
and also can be helpful for assisted reproductive technol-
ogy to avoid IVF failure with a remarkable reduction in in-
vestment of time and resources.
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